Oztürk Y, Altan V M, Ozçelikay A T, Yildizoğlu-Ari N
Department of Pharmacology, Faculty of Pharmacy, Ankara University, Turkey.
Arch Int Pharmacodyn Ther. 1992 May-Jun;317:81-92.
The beneficial effect of insulin on the decreased gastrointestinal beta-adrenergic responses in experimentally diabetic rats has been reported. The effects of streptozotocin-induced diabetes and insulin on the isolated rat duodenum, precontracted with bethanechol, were examined in the absence and in the presence of protein synthesis inhibitors in isometric conditions. Streptozotocin-induced diabetes caused a decrease of the beta-adrenergic responses of the rat duodenum. In vitro insulin treatment corrected the decreased beta-adrenergic responses of rat duodenum due to streptozotocin-induced diabetes. In the presence of protein synthesis inhibitors, actinomycin D or cycloheximide, the beneficial effect of insulin on the decreased intestinal beta-adrenergic responses was significantly inhibited. These findings suggest that the beneficial effect of insulin in the rat duodenum might be related to a new receptor synthesis.
胰岛素对实验性糖尿病大鼠胃肠道β-肾上腺素能反应降低具有有益作用,这一作用已见报道。在等容条件下,研究了链脲佐菌素诱导的糖尿病及胰岛素对预先用氨甲酰甲胆碱收缩的离体大鼠十二指肠的影响,实验分别在不存在和存在蛋白质合成抑制剂的情况下进行。链脲佐菌素诱导的糖尿病导致大鼠十二指肠β-肾上腺素能反应降低。体外胰岛素治疗纠正了链脲佐菌素诱导的糖尿病所致大鼠十二指肠β-肾上腺素能反应降低。在存在蛋白质合成抑制剂放线菌素D或环己酰亚胺的情况下,胰岛素对肠道β-肾上腺素能反应降低的有益作用被显著抑制。这些发现提示,胰岛素在大鼠十二指肠中的有益作用可能与新受体合成有关。